HK1059937A1 - Erythromycin derivative having novel crystal structures and processes for their production - Google Patents

Erythromycin derivative having novel crystal structures and processes for their production

Info

Publication number
HK1059937A1
HK1059937A1 HK04102744A HK04102744A HK1059937A1 HK 1059937 A1 HK1059937 A1 HK 1059937A1 HK 04102744 A HK04102744 A HK 04102744A HK 04102744 A HK04102744 A HK 04102744A HK 1059937 A1 HK1059937 A1 HK 1059937A1
Authority
HK
Hong Kong
Prior art keywords
processes
production
crystal structures
novel crystal
erythromycin derivative
Prior art date
Application number
HK04102744A
Other languages
English (en)
Inventor
Hitoshi Shimizu
Kaname Tsuzaki
Akira Hiraide
Kaichiro Koyama
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1059937A1 publication Critical patent/HK1059937A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
HK04102744A 2000-10-12 2004-04-19 Erythromycin derivative having novel crystal structures and processes for their production HK1059937A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000312220 2000-10-12
PCT/JP2001/008990 WO2002030943A1 (fr) 2000-10-12 2001-10-12 Derive d'erythromycine possedant des nouvelles structures cristallines et procedes associes de production

Publications (1)

Publication Number Publication Date
HK1059937A1 true HK1059937A1 (en) 2004-07-23

Family

ID=18791856

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102744A HK1059937A1 (en) 2000-10-12 2004-04-19 Erythromycin derivative having novel crystal structures and processes for their production

Country Status (11)

Country Link
US (1) US7645864B2 (xx)
EP (1) EP1334726A4 (xx)
JP (2) JP4275407B2 (xx)
KR (1) KR100540021B1 (xx)
CN (1) CN1231490C (xx)
AU (2) AU9424401A (xx)
CA (1) CA2425913C (xx)
HK (1) HK1059937A1 (xx)
RU (1) RU2264408C2 (xx)
TW (1) TWI286139B (xx)
WO (1) WO2002030943A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US8758724B2 (en) 2005-11-29 2014-06-24 Nihon Medi-Physics Co., Ltd. Unnatural amino acid radiolabeling precursor
US9273208B2 (en) * 2011-02-21 2016-03-01 Kaneka Corporation Acrylic resin film
CN102212094B (zh) * 2011-03-14 2013-08-21 金泳霖 一种红霉素残余药渣的处理工艺
CN102911226B (zh) * 2011-08-03 2015-11-25 胡梨芳 硬脂酸红霉素类化合物物实体及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY113693A (en) 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
ZA966601B (en) 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
SE9802974D0 (sv) * 1998-09-03 1998-09-03 Astra Ab New crystalline forms

Also Published As

Publication number Publication date
AU9424401A (en) 2002-04-22
RU2264408C2 (ru) 2005-11-20
CN1231490C (zh) 2005-12-14
KR20030042010A (ko) 2003-05-27
CA2425913A1 (en) 2003-04-11
JPWO2002030943A1 (ja) 2004-02-19
JP2009102356A (ja) 2009-05-14
TWI286139B (en) 2007-09-01
EP1334726A1 (en) 2003-08-13
WO2002030943A1 (fr) 2002-04-18
EP1334726A4 (en) 2005-12-14
AU2001294244B2 (en) 2005-02-17
JP4275407B2 (ja) 2009-06-10
US20030191296A1 (en) 2003-10-09
US7645864B2 (en) 2010-01-12
CA2425913C (en) 2008-07-15
CN1474828A (zh) 2004-02-11
KR100540021B1 (ko) 2005-12-29

Similar Documents

Publication Publication Date Title
PT1293507E (pt) Processo para produção de cristais
HUP0203875A3 (en) Microcapsule and process for production thereof
HUP0300418A3 (en) Method of preparing clarithromycin of form ii crystals
AU2001268690A1 (en) Manufacturing process for electrophoretic display
AU2001227573A1 (en) Ceramics and process for producing
GB0016523D0 (en) Inter-lockable structural panel sets
DE60017012D1 (de) Orginalitätsverschluss und Herstellungverfahren
AU2001285115A1 (en) Jewelry setting
AU8968101A (en) Electrochemical element and process for its production
HRP20020972A2 (en) Crystal modification
GB2378551B (en) Form production system
AU9424401A (en) Erythromycin derivative having novel crystal structures and processes for their production
AU2001294244A1 (en) Erythromycin derivative having novel crystal structures and processes for their production
AU2001232158A1 (en) Crystallizing process
AU2001264134A1 (en) Microconnectors and method for their production
AU8257701A (en) Process for producing erythromycin derivative
AU2001282577A1 (en) Process for producing erythromycin derivative
EP1310506A4 (en) METHOD FOR PRODUCING AN ERYTHROMYCINE DERIVATIVE
GB0020449D0 (en) Crystal structure
AU2001276782A1 (en) Process for the recovery of rhodium
EP1281723A4 (en) NEW PROCESS FOR THE PREPARATION OF POLYACETYLENE DERIVATIVES
AU2002234066A1 (en) Process for the production of amides
AU2001264931A1 (en) High-throughput purification process
AU7400401A (en) Method for the production of 2- coumarone and substituted 2-coumarones
EP1266905A4 (en) METHOD FOR PRODUCING PURIFIED ERYTHROMYCIN

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101012